The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Abstract

The risk of recurrent thrombosis in patients with the antiphospholipid-antibody syndrome is high. Long-term anticoagulation therapy in which the international normalized ratio is maintained at or above 3 is advisable in these patients.